Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

25 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Inflexibility of energy substrate oxidation in type 1 diabetic patients.
Wohl P, Wohl P, Girman P, Pelikánová T. Wohl P, et al. Metabolism. 2004 May;53(5):655-9. doi: 10.1016/j.metabol.2003.12.013. Metabolism. 2004. PMID: 15131773
Basal respiratory quotient (RQ) was lower in DM1 compared with C (0.72 +/- 0.04 v 0.75 +/- 0.04; P<.03). Insulin administration was accompanied by an increase in RQ in both groups, which was lower in DM1 compared with C (period 1: +0.09 +/- 0.04 v +0.11 +/- 0.07; P
Basal respiratory quotient (RQ) was lower in DM1 compared with C (0.72 +/- 0.04 v 0.75 +/- 0.04; P<.03). Insulin administration wa …
Intramyocellular lipid content in subjects with impaired fasting glucose after telmisartan treatment, a randomised cross-over trial.
Kratochvílová S, Škoch A, Wohl P, Švehlíková E, Dezortová M, Hill M, Hájek M, Pelikánová T. Kratochvílová S, et al. Among authors: wohl p. Magn Reson Imaging. 2016 Apr;34(3):353-8. doi: 10.1016/j.mri.2015.10.031. Epub 2015 Oct 31. Magn Reson Imaging. 2016. PMID: 26523653 Clinical Trial.
Telmisartan treatment resulted in a lower fasting plasma glucose (FPG) (p<0.05), but insulin action was comparable to after placebo. ...After placebo, IMCL correlated negatively with total cholesterol (p<0.001), MCR (p<0.05) and adiponectin (p
Telmisartan treatment resulted in a lower fasting plasma glucose (FPG) (p<0.05), but insulin action was comparable to after placeb …
Effect of telmisartan on selected adipokines, insulin sensitivity, and substrate utilization during insulin-stimulated conditions in patients with metabolic syndrome and impaired fasting glucose.
Wohl P, Krusinová E, Hill M, Kratochvílová S, Zídková K, Kopecký J, Neskudla T, Pravenec M, Klementová M, Vrbíková J, Wohl P, Mlejnek P, Pelikánová T. Wohl P, et al. Eur J Endocrinol. 2010 Oct;163(4):573-83. doi: 10.1530/EJE-10-0436. Epub 2010 Jul 14. Eur J Endocrinol. 2010. PMID: 20630944 Clinical Trial.
RESULTS: Fasting plasma glucose was lower after telmisartan compared with placebo (P<0.05). There were no differences in insulin sensitivity and substrate utilization. ...Insulin-stimulated plasma adiponectin (P<0.05), leptin and resistin (P<0.001) w …
RESULTS: Fasting plasma glucose was lower after telmisartan compared with placebo (P<0.05). There were no differences in insulin s …
Activation of alpha2-adrenergic receptors blunts epinephrine-induced lipolysis in subcutaneous adipose tissue during a hyperinsulinemic euglycemic clamp in men.
Stich V, Pelikanova T, Wohl P, Sengenès C, Zakaroff-Girard A, Lafontan M, Berlan M. Stich V, et al. Among authors: wohl p. Am J Physiol Endocrinol Metab. 2003 Sep;285(3):E599-607. doi: 10.1152/ajpendo.00502.2002. Am J Physiol Endocrinol Metab. 2003. PMID: 12900381 Clinical Trial.
Isoproterenol (1 microM)-induced lipolysis was reduced by 28 and 44% during hours 3 and 6 of the clamp, respectively, whereas the reduction of epinephrine (100 microM)-induced lipolysis was significantly greater (by 63 and 70%, P<0.01 and P<0.04, respectively) …
Isoproterenol (1 microM)-induced lipolysis was reduced by 28 and 44% during hours 3 and 6 of the clamp, respectively, whereas the reduction …
Urinary urea nitrogen excretion during the hyperinsulinemic euglycemic clamp in type 1 diabetic patients and healthy subjects.
Wohl P, Krusinová E, Klementová M, Wohl P, Kratochvílová S, Pelikánová T. Wohl P, et al. Physiol Res. 2008;57(2):247-52. Epub 2007 May 30. Physiol Res. 2008. PMID: 17552877
During the clamp, serum urea decreased significantly in both groups (p<0.01). Therefore, UEc was significantly lower as compared to UE not adjusted for changes in urea pool size both in C (p<0.001) and DM1 (p<0.001). While UE did not change during th …
During the clamp, serum urea decreased significantly in both groups (p<0.01). Therefore, UEc was significantly lower as compared t …
Effect of acute hyperinsulinaemia with and without angiotensin II type 1 receptor blockade on resistin and adiponectin concentrations and expressions in healthy subjects.
Krusinová E, Klementová M, Kopecký J, Wohl P, Kazdová L, Mlejnek P, Pravenec M, Hill M, Pelikánová T. Krusinová E, et al. Among authors: wohl p. Eur J Endocrinol. 2007 Oct;157(4):443-9. doi: 10.1530/EJE-07-0034. Eur J Endocrinol. 2007. PMID: 17893258 Clinical Trial.
Plasma resistin increased equally during HEC and AT-HEC (P<0.05). The expression of resistin in s.c. fat increased during HEC (P<0.05), while no significant changes in expression were observed during AT-HEC. ...Adiponectin expression increased during HEC (P
Plasma resistin increased equally during HEC and AT-HEC (P<0.05). The expression of resistin in s.c. fat increased during HEC ( …
Trace Element Status (Zinc, Copper, Selenium, Iron, Manganese) in Patients with Long-Term Home Parenteral Nutrition.
Dastych M Jr, Šenkyřík M, Dastych M, Novák F, Wohl P, Maňák J, Kohout P. Dastych M Jr, et al. Among authors: wohl p. Ann Nutr Metab. 2016;69(2):120-124. doi: 10.1159/000450763. Epub 2016 Oct 14. Ann Nutr Metab. 2016. PMID: 27736814
Retrospective Analysis of Bone Metabolism in Patients on Waiting List for Simultaneous Pancreas-Kidney Transplantation.
Kratochvílová S, Brunová J, Wohl P, Lánská V, Saudek F. Kratochvílová S, et al. Among authors: wohl p. J Diabetes Res. 2019 May 14;2019:5143021. doi: 10.1155/2019/5143021. eCollection 2019. J Diabetes Res. 2019. PMID: 31218231 Free PMC article.
Comparison of various strategies for colorectal cancer screening tests.
Wohl P, Bednařík M, Wohl P, Cervenka M, Spičák J. Wohl P, et al. Eur J Gastroenterol Hepatol. 2011 Nov;23(12):1157-64. doi: 10.1097/MEG.0b013e3283491438. Eur J Gastroenterol Hepatol. 2011. PMID: 21989120
Microbiome and Metabolome Profiles Associated With Different Types of Short Bowel Syndrome: Implications for Treatment.
Budinska E, Gojda J, Heczkova M, Bratova M, Dankova H, Wohl P, Bastova H, Lanska V, Kostovcik M, Dastych M, Senkyrik M, Krizova J, Mraz M, Hradecky J, Hajslova J, Lenicek M, Podzimkova K, Chalupsky K, Sedlacek R, Cahova M. Budinska E, et al. Among authors: wohl p. JPEN J Parenter Enteral Nutr. 2020 Jan;44(1):105-118. doi: 10.1002/jpen.1595. Epub 2019 Apr 29. JPEN J Parenter Enteral Nutr. 2020. PMID: 31032975
25 results
Jump to page
Feedback